River 3 Renal
New York
About River 3 Renal
River 3 Renal is a developer of novel therapies designed to target orphan diseases in the renal space. The company's technology has the potential to address the unmet need in several kidney diseases, by further improving the standard of care, enabling medical practitioners to treat patients in a better way. River 3 Renal was established in 2020 in New York, USA.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $40.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Jan 2021)
Industries & Categories
Health Care, Health Diagnostics, Medical
Canonical: https://fsome.com/organization/river-3-renal-130239 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.